{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:17:41Z","timestamp":1778822261557,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"START-Program of the Faculty of Medicine, RWTH Aachen"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jconrel.2013.05.018","type":"journal-article","created":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T16:02:49Z","timestamp":1370102569000},"page":"161-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder"],"prefix":"10.1016","volume":"170","author":[{"given":"M.","family":"Haupt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Thommes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Breitkreutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2013.05.018_bb0005","first-page":"486","article-title":"Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test","volume":"48","author":"Froehlich","year":"1998","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jconrel.2013.05.018_bb0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clinthera.2005.02.014","article-title":"Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly","volume":"27","author":"Scheife","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0015","first-page":"29","article-title":"Antimuscarinic drugs for the treatment of overactive bladder: are they really all the same? \u2014 A comparative review of data pertaining to pharmacological and physiological aspects","volume":"9","author":"Wiedemann","year":"2007","journal-title":"Eur. J. Geriatr."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0030","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1569-9056(09)60235-9","article-title":"Trospium chloride released from intravesically applied PLGA-based carriers decreases bladder contractility in an isolated whole pig bladder model","volume":"8","author":"von Walter","year":"2009","journal-title":"Eur. Urol. Suppl."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0035","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.clinthera.2005.05.008","article-title":"Trospium chloride for the treatment of overactive bladder with urge incontinence","volume":"27","author":"Singh-Franco","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2007.08.004","article-title":"On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles","volume":"123","author":"Packhaeuser","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.05.018_bb0045","first-page":"487","article-title":"Release of gentamicin sulphate from biodegradable PLGA-implants produced by hot melt extrusion","volume":"65","author":"Gosau","year":"2010","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2013.05.018_bb0050","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1018822002353","article-title":"pH and osmotic pressure inside biodegradable microspheres during erosion","volume":"16","author":"Brunner","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Anderson","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0060","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/S0142-9612(00)00101-0","article-title":"Synthetic biodegradable polymers as orthopedic devices","volume":"21","author":"Middleton","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2013.05.018_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2008.11.026","article-title":"Lipid extrudates as novel sustained release systems for pharmaceutical proteins","volume":"134","author":"Schulze","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.05.018_bb0070","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ejpb.2008.05.010","article-title":"Correlation of in vivo and in vitro release data for rh-INF alpha lipid implants","volume":"70","author":"Schwab","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2005.12.050","article-title":"Biocompatibility and erosion behavior of implants made of triglycerides and blends with cholesterol and phospholipids","volume":"314","author":"Guse","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0080","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1523-1755.2003.00840.x","article-title":"Pathophysiology of proteinuria","volume":"63","author":"D'Amico","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0085","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/sj.ki.5000133","article-title":"Detection of bile salt-dependent lipase, a 110kDa pancreatic protein, in urines of healthy subjects","volume":"69","author":"Comte","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0090","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0300-9084(88)90188-5","article-title":"Minireview on pancreatic lipase and colipase","volume":"70","author":"Chapus","year":"1988","journal-title":"Biochimie"},{"key":"10.1016\/j.jconrel.2013.05.018_bb0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0009-8981(82)90174-7","article-title":"Detection of colipase in serum and urine of pancreatitis patients","volume":"123","author":"Junge","year":"1982","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jconrel.2013.05.018_bb0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jchromb.2008.08.018","article-title":"Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC\u2013MS\/MS","volume":"873","author":"Alnouti","year":"2008","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0105","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jchromb.2008.05.008","article-title":"Quantitative profiling of bile acids in biofluids and tissues based on accurate mass high resolution LC\u2013FF-MS: compound class targeting in a metabolomics workflow","volume":"871","author":"Bobeldijk","year":"2008","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijpharm.2010.10.048","article-title":"Drug release mechanisms of compressed lipid implants","volume":"404","author":"Kreye","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2004.02.027","article-title":"Continuous release of rh-interferon alpha-2a from triglyceride matrices","volume":"97","author":"Mohl","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.05.018_bb0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1517\/17425247.5.3.291","article-title":"Lipid implants as drug delivery systems","volume":"5","author":"Kreye","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0125","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejpb.2008.08.020","article-title":"Immediate release pellets with lipid binders obtained by solvent-free cold extrusion","volume":"71","author":"Krause","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejpb.2008.05.015","article-title":"Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution","volume":"71","author":"Windbergs","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejps.2011.03.013","article-title":"Controlled release implants based on cast lipid blends","volume":"43","author":"Kreye","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijpharm.2003.10.017","article-title":"Melted glyceryl palmitostearate (GPS) pellets for protein delivery","volume":"271","author":"Pongjanyakul","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1081\/DDC-120016720","article-title":"Melt granulation and heat treatment for wax matrix-controlled drug release","volume":"29","author":"Zhang","year":"2003","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0150","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejpb.2011.02.011","article-title":"Drug release mechanisms of cast lipid implants","volume":"78","author":"Kreye","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0155","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0009-2509(00)00458-9","article-title":"Crystallization behaviour of fats and lipids \u2014 a review","volume":"56","author":"Sato","year":"2001","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2005.08.030","article-title":"Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms","volume":"314","author":"Guse","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0170","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1002\/jps.20210","article-title":"Role of blooming in determining the storage stability of lipid-based dosage forms","volume":"93","author":"Khan","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2013.05.018_bb0175","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1002\/jps.22574","article-title":"Cast lipid implants for controlled drug delivery: importance of the tempering conditions","volume":"100","author":"Kreye","year":"2011","journal-title":"J. Pharm. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913003088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913003088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T11:50:46Z","timestamp":1539604246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365913003088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0168365913003088"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.05.018","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}